Literature DB >> 2465110

Antisera to human IgE can also recognize IgA and IgM molecules as produced by selected B lymphoblastoid cell lines.

R W Hendriks1, A Thompson, M E Kraakman, A L Drayer, R K Schuurman.   

Abstract

A series of polyclonal and monoclonal anti-human IgE sera reacted with a panel of 11 selected IgA and IgM producing B lymphoblastoid cell lines (BLCLs) in cytoplasmic fluorescence, ELISA and immunoprecipitation assays. The reactions were discordant between the BLCLs and the individual antisera. The panel of 11 BLCLs was selected from over 500 BLCLs by an ELISA spot assay using a polyclonal anti-human IgE serum. The BLCLs produced exclusively IgM or IgA, both with either kappa or lambda light chains as shown by immunoprecipitation/PAGE and mRNA analyses. The data indicate that IgE antisera may recognize IgE-like epitopes on the variable parts of some IgM or IgA molecules. These reactivities of IgE antisera may lead to false positive results of serum IgE determinations. Selected BLCLs are useful targets for exposing such reactivities in IgE antisera.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465110      PMCID: PMC1541792     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Immunoglobulin heavy chain gene rearrangements in X-linked agammaglobulinemia.

Authors:  E J Mensink; R K Schuurman; J D Schot; A Thompson; F W Alt
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

2.  Heterogeneity of EBV-transformable human B lymphocyte populations.

Authors:  M A Chan; L D Stein; H M Dosch; N H Sigal
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Epstein-Barr virus-induced IgE production in limiting dilution cultures of normal human B cells.

Authors:  L D Stein; M A Chan; T Hibi; H M Dosch
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

4.  Anti-anti-IgE idiotypic antibodies mimic IgE in their binding to the Fc epsilon receptor.

Authors:  M Baniyash; Z Eshhar
Journal:  Eur J Immunol       Date:  1987-09       Impact factor: 5.532

5.  The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1986-02-27       Impact factor: 2.303

6.  Expression of restricted immunoglobulin isotypes in plasmacellular hyperplasia after allogeneic bone marrow transplantation.

Authors:  H J Schuurman; R W Hendriks; L F Verdonck; J van Baarlen; G C de Gast; R K Schuurman
Journal:  Scand J Immunol       Date:  1987-10       Impact factor: 3.487

7.  In vitro production of IgE by human peripheral blood mononuclear cells. II. Cells involved in the spontaneous IgE production in atopic patients.

Authors:  S Romagnani; G F Del Prete; E Maggi; R Troncone; G M Giudizi; F Almerigogna; M Ricci
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

8.  Lack of pokeweed mitogen-induced IgE formation in vitro by human peripheral blood mononuclear cells: detection of cross-reacting idiotypic determinants on polyclonal Ig by antibodies to a single IgE myeloma protein.

Authors:  H L Spiegelberg; J M Plummer; J Ruedi; L F Thompson; M H Mellon; R S Zeiger
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

9.  Duplication and deletion in the human immunoglobulin epsilon genes.

Authors:  E E Max; J Battey; R Ney; I R Kirsch; P Leder
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

10.  Activation of human B cells: involvement of surface immunoglobulin as evidenced by two biochemically distinct types of response to Staphylococcus aureus.

Authors:  P Scholten; R Schuurman; H Ploegh
Journal:  Hum Immunol       Date:  1986-05       Impact factor: 2.850

View more
  1 in total

1.  Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

Authors:  A Gorter; K M Krüse; P I Schrier; G J Fleuren; R J van de Griend
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.